WATCHMAN

DEVICE5 trials

Sponsors

Boston Scientific Corporation, Kansas City Heart Rhythm Institute, Insel Gruppe AG, University Hospital Bern, Population Health Research Institute, samir kapadia

Conditions

Acute BleedingAortic Valve DisorderAortic Valve StenosisAtrial FibrillationCerebrovascular StrokeChronic Kidney Disease

Phase 4

The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial

WithdrawnNCT02885545

Population Health Research InstituteAcute Bleeding, Cerebrovascular Stroke, Chronic Kidney Disease

Start: 2016-09-30End: 2018-03-05Updated: 2018-03-29

Unknown Phase

ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology

CompletedNCT00851578

Boston Scientific CorporationAtrial Fibrillation

Start: 2009-01-31End: 2013-12-31Target: 150Updated: 2015-01-27

Safety and Efficacy of Left Atrial Appendage Occlusion Devices

CompletedNCT01695564

Kansas City Heart Rhythm InstituteAtrial Fibrillation

Start: 2012-05-31End: 2018-02-28Updated: 2019-05-02

Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage

TerminatedNCT02678871

Insel Gruppe AG, University Hospital BernAortic Valve Disorder

Start: 2017-03-08End: 2022-12-31Updated: 2023-02-23

WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

CompletedNCT03173534

samir kapadiaAortic Valve Stenosis, Atrial Fibrillation

Start: 2017-12-15End: 2022-12-06Updated: 2024-05-22

Related Papers

Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation

Circulation2023-10-2437 citations

Transcatheter Aortic Valve Replacement and Left Atrial Appendage Closure

Structural Heart2018-09-19

Aortic Stenosis and Atrial Fibrillation Left Atrial Appendage Occlusion—Could We? If So, How and When?

Structural Heart2017-12-14

Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

2013-04-10508 citations